| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/15/1997 | US5648059 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 07/15/1997 | US5647974 Hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 07/12/1997 | CA2194730A1 Topical compositions for the treatment of skin diseases |
| 07/10/1997 | WO1997024373A1 Monoclonal antibody antagonists to haemopoietic growth factors |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024132A1 Allogeneic paracrine cytokine tumor vaccines |
| 07/10/1997 | WO1997024124A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024122A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024119A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | WO1997024115A1 Naphthalenecarboxylic acid derivatives |
| 07/10/1997 | WO1997007769A3 Chemical compounds |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241724A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241633A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/09/1997 | EP0782984A2 Process of preparing 2-2'-(1-Methyl-1,2-Ethanediylidene) bis (Hydrazine carboximidamide) |
| 07/09/1997 | EP0782983A2 Process of preparing 2,2'-(1-Methyl-1,2-Ethanediylidene) bis (Hydrazine carboximidamide) |
| 07/09/1997 | EP0782854A2 Use of isopropyl-2-(1,3-dithietan-2-ylidene)-2-(N-(4-methylthiazol-2-yl)carbamoyl)acetate as a cancer chemopreventive agent |
| 07/09/1997 | EP0782709A1 Detection and treatment of cancer |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782570A1 Substituted heteroaromatic compounds and their use in medicine |
| 07/09/1997 | EP0782456A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 07/09/1997 | EP0782452A1 Cell growth regulator |
| 07/09/1997 | EP0464084B1 Use of eicosapentaenoic acid for the treatment of cachexia |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154111A New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 07/09/1997 | CN1154110A Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/09/1997 | CN1154109A Semi-synthetic taxanes with anti-tumoural activity |
| 07/09/1997 | CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/09/1997 | CN1035380C Preparation method for trifluoromethane-sulfonyl derivative of 10-hydroxy-camptothecine |
| 07/08/1997 | US5646261 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use |
| 07/08/1997 | US5646159 Water-soluble esters of camptothecin compounds |
| 07/08/1997 | US5646150 Methods of using lavendamycin analogs |
| 07/08/1997 | US5646141 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645852 Butyric ester cyto-differtiating agents |
| 07/08/1997 | US5645835 Therapeutic antibody based fusion proteins |
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/08/1997 | US5645817 Granulocyte-binding antibody constructs, their preparation and use |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023494A1 Carbohydrate conjugated bio-active compounds |
| 07/03/1997 | WO1997023480A1 Novel integrin receptor antagonists |
| 07/03/1997 | WO1997023478A1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/1997 | WO1997023476A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER |
| 07/03/1997 | WO1997023473A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 07/03/1997 | WO1997023472A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023453A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | WO1997023451A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | WO1997023243A1 Branched hydrazone linkers |
| 07/03/1997 | WO1997023240A2 Conjugate comprising an active agent, a polypeptide and a polyether |
| 07/03/1997 | WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | WO1997023230A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | WO1997023211A1 Pharmaceutical compounds |
| 07/03/1997 | DE19548709A1 Tyrosinderivate Tyrosine derivatives |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241255A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | CA2241149A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | CA2241143A1 Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular na+/h+-antiporter |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241086A1 Pharmaceutical compounds |
| 07/03/1997 | CA2241011A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | CA2240439A1 Novel integrin receptor antagonists |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | CA2213489A1 Carbohydrate conjugated bio-active compounds |
| 07/02/1997 | EP0781845A2 Anti-human milk fat globule humanised antibodies and processes for their production |
| 07/02/1997 | EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 07/02/1997 | EP0781776A2 Water soluble rapamycin esters |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781343A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/1997 | EP0781334A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781331A1 Improvements in or relating to binding proteins for recognition of dna |
| 07/02/1997 | EP0781281A1 NOVEL MELATONIN AGONIST $g(b)-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS |
| 07/02/1997 | EP0781138A2 Lipid analogs for treating viral infections |
| 07/02/1997 | EP0781136A1 Compounds and methods for the treatment of cancer |